期刊文献+

实时荧光PCR法快速检测乙型肝炎病毒基因YMDD突变株 被引量:6

Rapid Detection of Hepatitis B Virus YMDD Gene Variant by Real-time Fluorescent PCR
下载PDF
导出
摘要 目的建立一种敏感、特异、快速的实时荧光PCR定量检测乙型肝炎病毒基因YMDD突变株的方法,为临床治疗提供指导。方法设计引物和TaqMan-MGB探针,利用TaqMan-MGB探针技术,建立实时荧光定量PCR法。检测临床HBV-YMDD变异标本36份和野生型HBV标本20份,并将其YMDD变异结果与DNA测序结果进行比较。结果该方法检测灵敏度为101拷贝/μl;特异性为100%;最低检测限度为101DNA拷贝/30μl反应体系;实时荧光PCR方法测得YMDD野生株20份,变异株36份,与DNA测序结果完全一致,符合率为100%。结论应用TaqMan-MGB探针的实时荧光定量PCR方法检测YMDD变异株基因,具有灵敏、特异和精确等优点,对临床监测拉米夫定耐药具有重要意义。 Objective To develop a sensitive, specific and rapid real-time fluorescent PCR for detection of hepatitis B (HB) virus YMDD gene variant and provide a basis for clinical treatment of HB. Methods Develop a real-time fluorescent PCR by using designed primers and TaqMan-MGB probe. Thirty-six chnical specimens of HBV-YMDD variants and 20 specimens of wild type HBV were detected by the developed real-time fluorescent PCR, and the results were compared with those of DNA sequencing. Results The sensitivity, specificity and minimum detection limit of the developed real-time fluorescent PCR were 10^1 copies/μl, 100% and 10^1 DNA copies/30μl reaction system respectively The detection result of developed PCR was completely consistent with that of DNA sequencing. Conclusion The developed real-time fluorescent PCR was sensitive, specific and accurate for the detection of HB virus YMDD gene variant and of important significance in clinical monitoring of resistance to lamivudine.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第4期333-335,342,共4页 Chinese Journal of Biologicals
关键词 乙型肝炎病毒 实时荧光PCR TAQMAN-MGB探针 YMDD变异株 Hepatitis B virus Real-time fluorescent PCR TaqMan-MGB probe YMDD variant
  • 相关文献

参考文献3

二级参考文献24

  • 1[1]Maddrey WC.Hepatitis B-an important public health issue.Clin Lab 2001; 47:51-55
  • 2[2]Lai CL,Ratziu V,Yuen MF,Poynard T.Viral hepatitis B.Lancet 2003; 362:2089-2094
  • 3[3]Manigold T,Rehermann B.Chronic hepatitis B and hepatocarcinogenesis:does prevention of "collateral damage"bring the cure? Hepatology 2003; 37:707-710
  • 4[4]Lai CL,Chien RN,Leung NW,Chang TT,Guan R,Tai DI,Ng KY,Wu PC,Dent JC,Barber J,Stephenson SL,Gray DF.A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group.N Engl JMed 1998; 339:61-68
  • 5[5]Leung NW,Lai CL,Chang TT,Guan R,Lee CM,Ng KY,Lim SG,Wu PC,Dent JC,Edmundson S,Condreay LD,Chien RN.Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates:results after 3 years of therapy.Hepatology 2001; 33:1527-1532
  • 6[6]Yuen MF,Lai CL.Treatment of chronic hepatitis B.Lancet Infect Dis 2001; 1:232-242
  • 7[7]Hu KQ.A Practical Approach to Management of Chronic Hepatitis B.Int J Med Sci 2005; 2:17-23
  • 8[8]Allen MI,Deslauriers M,Andrews CW,Tipples GA,Walters KA,Tyrrell DL,Brown N,Condreay LD.Identification and characterization of mutations in hepatitis B virus resistant to lamivudine.Lamivudine Clinical Investigation Group.Hepatology 1998; 27:1670-1677
  • 9[9]Gunthard HF,Frost SD,Leigh-Brown AJ,Ignacio CC,Kee K,Perelson AS,Spina CA,Havlir DV,Hezareh M,Looney DJ,Richman DD,Wong JK.Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.J Virol 1999; 73:9404-9412
  • 10[10]Jardi R,Buti M,Rodriguez-Frias F,Cotrina M,Costa X,Pascual C,Esteban R,Guardia J.Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.J Virol Methods 1999; 83:181-187

共引文献22

同被引文献44

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部